StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) shareholders

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$698.47+8.23 (+1.19%)

Close on Nov 18, 2026Market cap $55.03BP/E 49.1Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
94.5%
74M of 79M shares
Institutional holders
1,300
115 new, 106 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 53 sales
Net sold $58.43M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.7,599,0789.40%13G (passive) amendmentMar 31, 2025
Vanguard Capital Management5,976,4727.51%13G (passive)Mar 31, 2026
Vanguard Portfolio Management3,974,4725.04%13G (passive)Sep 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of IDXXValueChange% of portfolio
BlackRock, Inc.8,170,17810.37%$4.30B−195,3750.06%
Vanguard Capital Management LLC5,152,2136.54%$2.71B−30,2940.06%
Vanguard Portfolio Management LLC3,896,5214.95%$2.05B−14,3420.09%
State Street Corp3,748,6604.76%$1.97B+74,4750.06%
Invesco Ltd.3,611,4164.58%$1.90B+261,7390.15%
Geode Capital Management, LLC2,562,8863.25%$1.35B−98,1130.07%
Bamco Inc /Ny/1,976,7782.51%$1.04B+343,4111.56%
Morgan Stanley1,356,1031.72%$713.91M+40,1490.04%
Bank of New York Mellon Corp1,193,3431.51%$628.22M−311,1890.10%
Arrowstreet Capital, Limited Partnership1,067,0781.35%$561.75M+228,2390.25%
Fundsmith LLP1,019,8871.29%$536.91M−445,8993.93%
Blair William & Co/Il918,5561.17%$483.56M−27,7801.26%
Northern Trust Corp918,1371.17%$483.34M+6,2440.06%
UBS Asset Management Americas Inc911,4891.16%$479.84M+39,7000.09%
FMR LLC822,6431.04%$433.07M+539,6670.02%
American Century Companies Inc808,3581.03%$425.55M+208,4270.19%
Capital Research Global Investors789,1111.00%$415.47M+7,7660.06%
JPMorgan Chase & Co755,7910.96%$405.05M−24,0910.02%
Principal Financial Group Inc743,2460.94%$391.30M−137,9430.19%
Goldman Sachs Group Inc738,7080.94%$388.89M+21,7870.03%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20261,30074M94.5%115 / 477505 / 1066M5M
Q1 20261,31873M93.2%125 / 432521 / 17415M14M
Q4 20251,38683M100.0%191 / 484481 / 8016M6M
Q3 20251,30373M92.9%162 / 420488 / 755M6M
Q2 20251,23575M95.2%199 / 423421 / 947M6M
Q1 20251,14374M94.2%123 / 466356 / 898M6M
Q4 20241,12472M91.8%165 / 338440 / 1418M10M
Q3 20241,11774M93.9%105 / 364430 / 8713M5M
Q2 20241,11076M96.0%84 / 421386 / 1076M6M
Q1 20241,14776M96.3%97 / 404413 / 885M4M
Q4 20231,15475M95.4%189 / 348428 / 816M5M
Q3 20231,06074M94.0%89 / 386386 / 864M3M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

937 funds held IDXX in Q2 2026, 49% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of IDXXValue% of fundAs of
Vanguard Total Stock Market Index Fund2,504,3273.18%$1.32B0.06%Jun 30, 2026
Vanguard 500 Index Fund2,043,0872.59%$1.08B0.06%Jun 30, 2026
Vanguard Mid-Cap Index Fund1,709,2092.17%$899.80M0.40%Jun 30, 2026
Invesco QQQ Trust, Series 11,674,4632.13%$881.50M0.18%Jun 30, 2026
iShares Core S&P 500 ETF1,085,2591.38%$571.32M0.06%Jun 30, 2026
Fidelity 500 Index Fund1,021,8541.30%$575.85M0.07%May 31, 2026
Vanguard Growth Index Fund942,2891.20%$496.06M0.13%Jun 30, 2026
Baron Partners Fund846,3001.07%$445.53M2.47%Jun 30, 2026
AMCAP Fund732,8610.93%$412.99M0.42%May 31, 2026
Vanguard Mid-Cap Growth Index Fund604,3330.77%$318.15M0.91%Jun 30, 2026
State Street(R) Health Care Select Sector SPDR(R) ETF557,2400.71%$293.35M0.72%Jun 30, 2026
Vanguard Institutional Index Fund428,2700.54%$225.46M0.06%Jun 30, 2026
Vanguard U.S. Growth Fund425,4150.54%$239.73M0.50%May 31, 2026
iShares Russell Mid-Cap Growth ETF391,9320.50%$206.33M0.96%Jun 30, 2026
Invesco NASDAQ 100 ETF338,5230.43%$190.77M0.20%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Jonathan Jay MazelskyExecutive Chair of the Board, Director83,8030.11%Nov 5, 2026
George FennellExecutive Vice President12,1820.02%Nov 12, 2026
Michael LaneExecutive Vice President4,6680.01%Nov 5, 2026
Sharon E. UnderbergEVP, GC & Corporate Secretary7,1690.01%Nov 5, 2026
Andrew EmersonEVP, CFO and Treasurer4,5070.01%Aug 24, 2026
Nimrata HuntExecutive Vice President18,3010.02%Mar 5, 2026
Michael G. EricksonExecutive Vice President15,0920.02%Mar 3, 2026
Michael Perkins JohnsonExecutive Vice President2,7950.00%Feb 17, 2026
Martin Alexander SmithExecutive Vice President1,6030.00%Feb 17, 2026
Michael SchreckExecutive Vice President2,1230.00%Feb 17, 2026
Brian P. McKeonEVP, CFO and Treasurer49,6000.06%Feb 18, 2025
Daniel M. JuniusDirector2,3610.00%Nov 5, 2026
Joseph L. HooleyDirector3730.00%Nov 3, 2026
Lawrence D. KingsleyDirector9,5680.01%Sep 9, 2026
Irene Chang BrittDirector2080.00%May 14, 2026
Bruce L. ClaflinDirector1,7210.00%May 14, 2026
Sam SamadDirector0–May 14, 2026
Stuart EssigDirector2,2360.00%May 14, 2026
Karen PeacockDirector1020.00%May 14, 2026
Sophie V. VandebroekDirector9,0780.01%May 14, 2026
M. Anne SzostakDirector2,3200.00%May 11, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
George Fennell
Executive Vice President
Nov 10, 2026Option exercise+483$206.94$99.95K12,182
George Fennell
Executive Vice President
Nov 10, 2026Option exercise+560$178.26$99.83K11,699
George Fennell
Executive Vice President
Nov 10, 2026Option exercise+706$141.60$99.97K11,139
Sharon E. Underberg
EVP, GC & Corporate Secretary
Nov 4, 2026Sale−1,055$690.02$727.97K7,169
Sharon E. Underberg
EVP, GC & Corporate Secretary
Nov 4, 2026Sale−1,503$689.05$1.04M8,224
Sharon E. Underberg
EVP, GC & Corporate Secretary
Nov 4, 2026Sale−6,348$688.25$4.37M9,727
Sharon E. Underberg
EVP, GC & Corporate Secretary
Nov 4, 2026Option exercise+8,906$288.78$2.57M16,075
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−331$711.95$235.65K83,803
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−775$711.31$551.26K84,134
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−1,501$710.12$1.07M84,909
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−1,300$709.00$921.70K86,410
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−1,840$707.84$1.30M87,710
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−840$707.00$593.88K89,550
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−240$705.59$169.34K90,390
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−3,950$703.45$2.78M90,630
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−2,136$702.21$1.50M94,580
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−4,540$701.36$3.18M96,716
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−1,667$700.33$1.17M101,256
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−4,075$699.33$2.85M102,923
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Sale−1,945$698.26$1.36M106,998
Jonathan Jay Mazelsky
Executive Chair of the Board, Director
Nov 4, 2026Option exercise+25,140$178.26$4.48M108,943
Michael Lane
Executive Vice President
Nov 4, 2026Sale−1,677$687.46$1.15M4,076
Michael Lane
Executive Vice President
Nov 4, 2026Sale−2,059$689.70$1.42M5,753
Michael Lane
Executive Vice President
Nov 4, 2026Sale−242.944$687.85$167.11K7,812
Daniel M. Junius
Director
Nov 4, 2026Sale−500$701.68$350.84K2,361
Daniel M. Junius
Director
Nov 4, 2026Sale−700$705.78$494.05K2,861
Joseph L. Hooley
Director
Oct 30, 2026Award+48$551.21$26.46K373
Lawrence D. Kingsley
Director
Sep 4, 2026Sale−2,203$532.08$1.17M9,568
Lawrence D. Kingsley
Director
Sep 4, 2026Option exercise+2,203$114.17$251.52K11,771
Andrew Emerson
EVP, CFO and Treasurer
Aug 20, 2026Option exercise+265$178.26$47.24K4,507
Andrew Emerson
EVP, CFO and Treasurer
Aug 20, 2026Tax withholding−86––4,421
Joseph L. Hooley
Director
Jul 30, 2026Award+49$558.80$27.38K325
George Fennell
Executive Vice President
Jun 1, 2026Option exercise+639––10,717
George Fennell
Executive Vice President
Jun 1, 2026Tax withholding−284$566.79$160.97K10,433
Lawrence D. Kingsley
Director
May 7, 2026Option exercise+82––9,568
Lawrence D. Kingsley
Director
May 7, 2026Option exercise+257––9,486
M. Anne Szostak
Director
May 7, 2026Option exercise+257––519
Daniel M. Junius
Director
May 7, 2026Option exercise+257––3,561
Karen Peacock
Director
May 7, 2026Option exercise+101––102
Joseph L. Hooley
Director
May 7, 2026Option exercise+158––276
Sophie V. Vandebroek
Director
May 7, 2026Option exercise+257––905
Joseph L. Hooley
Director
Apr 30, 2026Award+43$560.80$24.11K118
Nimrata Hunt
Executive Vice President
Mar 3, 2026Sale−1,758$634.57$1.12M18,141
Sharon E. Underberg
EVP, GC & Corporate Secretary
Mar 3, 2026Option exercise+197$505.53$99.59K7,138
Jonathan Jay Mazelsky
President and CEO, Director
Feb 27, 2026Option exercise+197$505.53$99.59K83,803
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−3,660$658.92$2.41M91,254
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−1,343$656.85$882.15K97,774
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−1,488$655.85$975.90K99,117
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−1,111$654.63$727.29K100,605
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−1,171$653.68$765.46K101,716
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−1,669$652.49$1.09M102,887
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−2,859$659.75$1.89M88,395
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−1,200$661.10$793.32K87,195
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−1,000$662.16$662.16K86,195
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−2,589$663.04$1.72M83,606
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Option exercise+23,326$141.60$3.30M106,932
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−1,281$650.67$833.51K105,651
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−1,095$651.49$713.38K104,556
Jonathan Jay Mazelsky
President and CEO, Director
Feb 26, 2026Sale−2,860$657.84$1.88M94,914
Nimrata Hunt
Executive Vice President
Feb 26, 2026Sale−2,693$661.54$1.78M19,899

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
3.00%
2M shares short
Days to cover
4.5
At 1M shares a day
Change since last report
+22.0%
From 2M shares
Short volume, 20 days
54.8%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of IDEXX Laboratories's stock actually held short. Settlement fails (shares not delivered on time) peaked at 824 shares on Sep 10, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Daniel M. Junius
Director
Nov 5, 20261,200$839.88KNov 4, 2026Open Market Purchase
Daniel M. Junius
Director
Nov 4, 2026500$345.84KNov 4, 2026Open Market Purchase
Michael Lane
Officer
Nov 4, 20263,979$2.74MNov 4, 2026Employee Stock Purchase Plan
Sharon E. Underberg
Officer
Nov 4, 20268,906$6.13MNov 4, 2026Stock Option Exercise
Jonathan Jay Mazelsky
Officer, Director
Nov 4, 202625,140$17.68MNov 4, 2026Stock Option Exercise
Lawrence D. Kingsley
Director
Sep 4, 20262,203$1.17MSep 4, 2026Stock Option Exercise
M. Anne Szostak
Director
May 20, 20261,344$744.01KMay 20, 2026Acquired as compensation -- Restricted Stock Units
Nimrata Hunt
Officer
Mar 3, 20261,758$1.12MMar 3, 2026Exercised Shares
Jonathan Jay Mazelsky
Officer, Director
Feb 26, 202623,326$15.34MFeb 26, 2026Stock Option Exercise
Nimrata Hunt
Officer
Feb 25, 20262,693$1.78MFeb 25, 2026Exercised Shares
Sophie V. Vandebroek
Director
Feb 17, 20261,464$920.29KFeb 17, 2026Restricted Stock
Michael G. Erickson
Officer
Feb 17, 20265,371$3.37MFeb 17, 2026Stock Option Exercise
George Fennell
Officer
Feb 10, 202611,345$7.34MFeb 10, 2026Stock Option Exercise
Nimrata Hunt
Officer
Nov 7, 20259,425$6.63MNov 7, 2025Stock Option Exercise
M. Anne Szostak
Director
Aug 22, 20252,187$1.42MAug 22, 2025Stock Option Exercise

Congress trades

34 trades in IDEXX Laboratories reported by 9 members of the House

MemberTypeTradedAmountFiled
April McClain Delaney
MD06 · child
SoldJan 13, 2026$1K–15KFeb 2, 2026
April McClain Delaney
MD06 · child
Sold (part)Oct 16, 2025$1K–15KNov 4, 2025
Byron Donalds
FL19 · spouse
BoughtSep 4, 2025$1K–15KOct 7, 2025
Byron Donalds
FL19
BoughtSep 4, 2025$1K–15KOct 7, 2025
April McClain Delaney
MD06 · child
Sold (part)Aug 7, 2025$1K–15KSep 2, 2025
April McClain Delaney
MD06 · child
Sold (part)Jul 9, 2025$1K–15KAug 5, 2025
Rob Bresnahan
PA08
BoughtMay 15, 2025$1K–15KJun 9, 2025
Jefferson Shreve
IN06
SoldMay 12, 2025$100K–250KJun 22, 2025
April McClain Delaney
MD06 · child
BoughtApr 9, 2025$1K–15KMay 2, 2025
Rob Bresnahan
PA08
SoldApr 8, 2025$1K–15KApr 28, 2025
Jefferson Shreve
IN06
BoughtApr 7, 2025$50K–100KMay 8, 2025
April McClain Delaney
MD06 · child
BoughtApr 7, 2025$1K–15KMay 2, 2025
April McClain Delaney
MD06 · child
BoughtApr 4, 2025$1K–15KMay 2, 2025
April McClain Delaney
MD06 · child
BoughtApr 1, 2025$1K–15KMay 2, 2025
April McClain Delaney
MD06 · child
BoughtMar 14, 2025$1K–15KApr 2, 2025
Jefferson Shreve
IN06
BoughtMar 13, 2025$15K–50KApr 11, 2025
Rob Bresnahan
PA08
BoughtFeb 25, 2025$1K–15KMar 27, 2025
Diana Harshbarger
TN01 · joint account
BoughtAug 24, 2022$1K–15KSep 27, 2022
Diana Harshbarger
TN01
BoughtAug 24, 2022$1K–15KSep 27, 2022
Peter Meijer
MI03
SoldFeb 16, 2021$1K–15KMar 16, 2021
Gilbert Cisneros
CA31
Sold (part)Oct 9, 2020$1K–15KNov 5, 2020
Gilbert Cisneros
CA31
Sold (part)Aug 11, 2020$1K–15KSep 14, 2020
Gilbert Cisneros
CA31
Sold (part)Jun 10, 2020$1K–15KJul 17, 2020
Gilbert Cisneros
CA31
BoughtApr 9, 2020$1K–15KMay 13, 2020
Gilbert Cisneros
CA31
Sold (part)Jun 3, 2019$1K–15KJun 18, 2019
Gilbert Cisneros
CA31
BoughtFeb 27, 2019$1K–15KMar 8, 2019
Gilbert Cisneros
CA31
BoughtFeb 26, 2019$1K–15KMar 8, 2019
Lamar Smith
TX21
SoldJun 2, 2015$1K–15KJul 13, 2015
K. Michael Conaway
TX11
SoldFeb 10, 2015$1K–15KMar 3, 2015
K. Michael Conaway
TX11
SoldFeb 9, 2015$1K–15KMar 3, 2015
Lamar Smith
TX21
BoughtOct 6, 2014$1K–15KNov 12, 2014
Lamar Smith
TX21
SoldApr 2, 2014$1K–15KMay 6, 2014
Lamar Smith
TX21
SoldMar 11, 2014$1K–15KApr 7, 2014
Lamar Smith
TX21
SoldFeb 18, 2014$1K–15KMar 12, 2014

See a number that looks wrong?